Company profile for AKL Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

AKL Research & Development Limited, trading as AKL Therapeutics, is based at the Stevenage Bioscience Catalyst, Stevenage, Herts UK. AKL identifies and synthesizes secondary metabolites of plant origin with proven efficacy & safety. This innovative approach greatly increases the chances of success, while reducing the probability of unexpected side effects. AKL is focused on developing its lead clinical asset APPA, a novel ther...
AKL Research & Development Limited, trading as AKL Therapeutics, is based at the Stevenage Bioscience Catalyst, Stevenage, Herts UK. AKL identifies and synthesizes secondary metabolites of plant origin with proven efficacy & safety. This innovative approach greatly increases the chances of success, while reducing the probability of unexpected side effects. AKL is focused on developing its lead clinical asset APPA, a novel therapeutic for inflammatory diseases where there is a high unmet need, including osteoarthritis (OA) and other complex diseases of ageing.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Herts SG1 2FX
Telephone
Telephone
+44 (1438 ) 906906
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/new-data-presented-at-oarsi-2021-virtual-world-congress-by-akl-research-and-development-advances-understanding-of-biological-effects-of-its-investigational-osteoarthritis-drug-appa-to-protect-against-joint-damage-301279586.html

PRNEWSWIRE
29 Apr 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty